Guanze Medical Information Industry (Holding) Co., Ltd.（下称“GUANZE MEDICAL”，股票代码02427）于2026年5月4日发布截至2026年4月30日的证券变动月报表。公告显示，公司法定注册股本维持为100,000,000港元，对应已发行及注册股份数目合计10,000,000,000股，每股面值0.01港元。
报告期内，公司已发行普通股数量为950,000,000股，与上月末保持一致；未持有任何库存股份。本月无新增股份发行、购回或注销活动，亦无股份期权、权证、可换股票据及其他股权激励安排的变动。
截止本期末，公司股本总数继续保持稳定，符合香港联合交易所有限公司相关上市规则要求。公告由公司秘书郑章劲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.